VCEL241220C45000
- 0.00
- 0.000.00%
Vericel Newsroom
Leerink Partners Sticks to Its Buy Rating for Vericel (VCEL)
BTIG Maintains Vericel(VCEL.US) With Buy Rating, Raises Target Price to $66
Vericel Price Target Raised to $66 From $56 at BTIG
Express News | Vericel Corp : Leerink Partners Raises Target Price to $64 From $57
Vericel Is Maintained at Buy by Canaccord Genuity
Vericel Analyst Ratings
CCORF Maintains Vericel(VCEL.US) With Buy Rating, Maintains Target Price $60
CCORF Maintains Vericel(VCEL.US) With Buy Rating, Raises Target Price to $60
Truist Financial Maintains Vericel(VCEL.US) With Buy Rating, Announces Target Price $61
TD Cowen Maintains Vericel(VCEL.US) With Buy Rating, Maintains Target Price $60
H.C. Wainwright Maintains Vericel(VCEL.US) With Buy Rating, Maintains Target Price $60
Ladenburg Thalmann Maintains Vericel(VCEL.US) With Buy Rating, Raises Target Price to $56
A Quick Look at Today's Ratings for Vericel(VCEL.US), With a Forecast Between $56 to $60
Vericel Corporation (VCEL) Q3 2024 Earnings Conference Call Transcript Summary
Vericel Price Target Raised to $56 From $55 at BTIG
Vericel | 10-Q: Q3 2024 Earnings Report
Vericel Reports Q3 EPS (2c), Consensus (5c)
Vericel | 8-K: Press Release of Vericel Corporation, “Vericel Reports Third Quarter 2024 Financial Results”
Express News | Vericel Q3 Adjusted Ebitda Margin 17%
Express News | Vericel Q3 Adjusted Ebitda USD 10 Million Vs. IBES Estimate USD 7.53 Million